Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

4.05
Delayed Data
As of Jul 31
 -0.08 / -1.94%
Today’s Change
1.76
Today|||52-Week Range
4.67
+24.62%
Year-to-Date

Today’s Trading

Previous close4.13
Today’s open4.11
Day’s range4.00 - 4.15
Volume1,511,732
Average volume (3 months)2,268,286
Market cap$667.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+23.33%
Earnings growth (this year)+101.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.13%
P/E ratioNM
Price/Sales432.79
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
ALRPRBAlere Inc+8.25+2.50%
QDELQuidel Corp-0.25-1.19%
VIVOMeridian Bioscience ...-0.09-0.50%
GHDXGenomic Health Inc+0.74+2.81%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.2M
Annual profit (last year)-$35.7M
Net profit margin-3,093.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts